In Reply It is encouraging to see the growing interest in avoiding COI on practice guidelines panels. The RIGHT checklist is a step in the right direction.1
Ms Morciano and colleagues call for government action to regulate the management of COI in guidelines when guideline producers fail to deal with the problem. This approach may be successful in some countries, and it will be interesting to share experiences of this type. However, a market-based approach is more likely to succeed in countries like the United States. The National Guidelines Clearinghouse, a government-sponsored entity, is a marketplace for clinical practice guidelines. Guideline producers want access to the marketplace, so requiring a strong COI policy as the price of access seems worth trying.
Sox HC. Managing Conflicts of Interest in Practice Guidelines Panels—Reply. JAMA. 2017;318(9):868. doi:10.1001/jama.2017.9680
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: